Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q4 2021 call → NOThe question asks whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. I need to look for two halves: (1) a mispricing claim anchored to something concrete, and (2) the company acting on it with real resources already in motion. Looking through the transcript, management discusses: - The company's strategy shift from component vendor to solutions partner - Growth trajectory - China operations cleanup - Yield issues and margin problems - New hires and team building - Board changes - Executive bonus program Management talks about the company being "very well-positioned" to become a photonics partner, and discusses investments in manufacturing, R&D, and expansion. There's discussion of the Orlando facility consolidation and expansion, and investments in Riga. However, I don't see management asserting that the market or outsiders are undervaluing the company or its assets relative to something concrete and verifiable. There's no discussion of a buyback, insider purchases, or the company deliberately retaining or concentrating exposure because it believes assets are mispriced. Management expresses confidence and optimism about the strategy, but doesn't anchor any undervaluation claim to a specific benchmark or arithmetic. The discussion of the China situation involves costs and cleanup, not mispricing. The margin discussion is about operational issues, not about the market mispricing the company. There's no mention of the company buying back shares, acquiring assets at prices management calls low, or refusing to sell something at inadequate prices. The company is investing in growth, but that's presented as routine capital allocation for expansion, not as a response to mispricing. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.